Preclinical mass spectrometry imaging – an indispensable tool in neuropharmacology research

This webinar looks at the applications of MSI in neuropharmacology research, including drug distribution and the use of MSI in understanding the pathogenesis of neurocognitive disorders.

In recent times mass spectrometry imaging (MSI) has been gaining popularity in the pharmaceutical industry for its multitude of uses in preclinical drug development. In this webinar we will discuss the applications of MSI in neuropharmacology research, including the brain distribution of drugs used in the treatment of neurological disorders and the use of MSI in understanding the pathogenesis of neurocognitive disorders. This talk will also include tips, tricks and points of consideration in the planning, design and execution of preclinical MSI experiments in neuropharmacology research.

What will you learn?

  • The basic MSI workflow used in preclinical neuropharmacology research
  • Advantages and disadvantages of currently available MSI modalities
  • Applications of MSI in the study of drug distribution
  • How MSI can be used to unravel neural pathways in the brain

Who may this interest?

  • Mass spectrometry researchers
  • Postgraduate students
  • Scientists
  • R&D scientists at big pharma

Speaker

BRSA headshotsSooraj Baijnath

Academic Leader/Co-Principal Investigator

University of KwaZulu-Natal (Durban, South Africa)

Sooraj Baijnath is currently the Academic Leader of Research and Principal Investigator at the Catalysis and Peptide Research Unit at the University of KwaZulu-Natal, South Africa. In his brief career he has received many accolades including the National Research Foundation Next Generation Researcher Award in 2016 and the College of Health Sciences Best Emerging Teacher Award in 2018. He has also trained and graduated a number of postgraduate students and serves as a reviewer for a number of highly ranked international journals.

In association with:

Waters_logo